Financial Architects, Inc Idera Pharmaceuticals, Inc. Transaction History

Financial Architects, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $3,128 - $5,240	-1,320 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$2.33 - $3.79 $3,075 - $5,002	1,320 New	1,320 $3,000
Q1 2019 May 03, 2019	SELL	$2.33 - $3.79 $3,075 - $5,002	-1,320 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$2.77 - $9.38 $385 - $1,303	139 Added 11.77%	1,320 $4,000
Q3 2018 Oct 29, 2018	BUY	$5.53 - $11.36 $6,530 - $13,416	1,181 New	1,181 $11,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.